4th Congress of the Spanish Society of TransplantationKidney transplantationShort-Term Outcomes of 100 Consecutive Kidney Transplantations in a 3-Year Period: A Single-Center Experience

- We have noted great improvement in the early results of renal transplantation in recent years, including complex cases.
- Further dedicated prospective studies aimed to evaluate or to propose possible recipient-related predictors for kidney transplantation outcomes in different populations are needed.
- The eGFR can be used to assess renal function and also is well known in its role in predicting long-term renal function.

BackgroundThe results of kidney transplantation have improved significantly in the last decade with patient and graft survival rates that range from 92% to 95%.MethodsWe analyzed the clinical results in the last 100 consecutive patients with a follow-up of 6-42 months at our institution. We also made a general evaluation of the patients before surgery as candidates for transplantation and divided them into 3 groups (good, moderate, and poor).ResultsWe had 8 living donors and 92 cadaveric kidney transplantation cases. Principal cause of donor death was cerebrovascular disease accounting for 64%. Mean age of recipients was 55.1 ± 12.9 years with a total of 65 males. Currently there are 96 functioning allografts. During this 3-year period, 2 patients suffered graft loss and 2 patients died with a functioning allograft. We studied whether there were statistically significant differences in renal function (Modification of Diet in Renal Disease Study Equation [MDRD]) at 12 months and at last visit with respect to the evaluation of recipient as candidate for renal transplantation.ConclusionOur observations suggest great improvement of early results of renal transplantation in recent years, including complex cases. In this 3-year period we had a patient survival rate of 98% and a graft survival rate of 96% of cases. Further dedicated prospective studies that aim to evaluate or to propose possible recipient-related predictors for kidney transplantation outcomes in different populations are needed.